Mitochondrial diseases: therapeutic approaches (Q36814472)

16 August 2017

1 reference

title

Mitochondrial diseases: therapeutic approaches (English)

1 reference

16 August 2017

1

Salvatore DiMauro

1 reference

16 August 2017

Michelangelo Mancuso

2

1 reference

16 August 2017

1 June 2007

1 reference

16 August 2017

1 reference

16 August 2017

27

1 reference

16 August 2017

125-137

1 reference

16 August 2017

1-3

1 reference

https://scigraph.springernature.com/pub.10.1007/s10540-007-9041-4

16 August 2017

0 references

cites work

Evaluation of bupivacaine-induced muscle regeneration in the treatment of ptosis in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS10540-007-9041-4

Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10540-007-9041-4

Severe hypermetabolism with primary abnormality of skeletal muscle mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10540-007-9041-4

Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mitochondrial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10540-007-9041-4

Cerebral lactic acidosis correlates with neurological impairment in MELAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10540-007-9041-4

10.1007/S10540-007-9041-4

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17486439